Korea Investment CORP cut its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 0.7% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 207,235 shares of the company’s stock after selling 1,383 shares during the period. Korea Investment CORP’s holdings in Express Scripts Holding were worth $13,230,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of ESRX. Meyer Handelman Co. boosted its stake in Express Scripts Holding by 1.8% in the first quarter. Meyer Handelman Co. now owns 12,833 shares of the company’s stock worth $846,000 after buying an additional 233 shares during the period. Dillon & Associates Inc. boosted its stake in Express Scripts Holding by 5.6% in the first quarter. Dillon & Associates Inc. now owns 6,735 shares of the company’s stock worth $445,000 after buying an additional 355 shares during the period. Oakworth Capital Inc. boosted its stake in Express Scripts Holding by 7.0% in the first quarter. Oakworth Capital Inc. now owns 2,362 shares of the company’s stock worth $155,000 after buying an additional 155 shares during the period. IFP Advisors Inc boosted its stake in Express Scripts Holding by 3.1% in the first quarter. IFP Advisors Inc now owns 15,230 shares of the company’s stock worth $1,004,000 after buying an additional 457 shares during the period. Finally, Asset Advisors Corp purchased a new stake in Express Scripts Holding during the first quarter worth approximately $1,054,000. Institutional investors own 88.70% of the company’s stock.

Shares of Express Scripts Holding Company (ESRX) opened at 61.53 on Thursday. Express Scripts Holding Company has a one year low of $57.80 and a one year high of $77.50. The stock has a market cap of $35.54 billion, a price-to-earnings ratio of 10.68 and a beta of 0.90. The firm has a 50-day moving average price of $61.89 and a 200-day moving average price of $63.95.

Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.71 by $0.02. The business had revenue of $25.35 billion during the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. Express Scripts Holding’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.57 earnings per share. Analysts anticipate that Express Scripts Holding Company will post $6.99 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/31/korea-investment-corp-has-13-23-million-position-in-express-scripts-holding-company-esrx.html.

A number of analysts have recently commented on the company. Morgan Stanley lifted their target price on Express Scripts Holding from $52.00 to $57.00 and gave the stock an “underweight” rating in a research report on Thursday, August 10th. Needham & Company LLC started coverage on Express Scripts Holding in a research report on Friday, July 21st. They set a “hold” rating on the stock. ValuEngine lowered Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. BidaskClub lowered Express Scripts Holding from a “sell” rating to a “strong sell” rating in a report on Friday, August 4th. Finally, Jefferies Group LLC set a $72.00 price target on Express Scripts Holding and gave the stock a “buy” rating in a report on Tuesday. Four research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $70.03.

In related news, VP Everett Neville sold 1,163 shares of the business’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the sale, the vice president now directly owns 18,232 shares of the company’s stock, valued at $1,120,903.36. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.